Flow CAST® Peanut Trial
ConditionPeanut Allergies
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorBühlmann Laboratories AG
About this trial
This will be a multi-center, prospective evaluation, conducted at a minimum of four (4) U.S. sites. Sites will enroll peanut allergic subjects, subjects with allergies other than peanut and apparently healthy non-atopic control subjects and collect blood samples for testing using Flow CAST® and the comparative ImmunoCAP sIgE test.
Eligibility criteria
Qualifiers
Individual undergoing a blood draw
Individual willing and able to provide two additional tubes of blood (3ml each tube) for research purposes
Individual or legal guardian will and able to sign the informed consent form to participate in the study
Disqualifiers
Individual has undergone immunotherapy for peanuts or other identified allergens that have been shown to cause allergic symptoms
Individual has been exposed to systemically administered glucocorticoids within the last 24 hours.
Individual has been recently exposed to small molecule immunosuppressive medications
Individual has been recently exposed to treatment with biologics interfering with the type-I allergic pathway
Trial design
Treatments tested in this trial
- Basophil activation test
Treatment groups
245 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov